Don't miss out on the world's largest gathering of users and producers of health services research, #ARM24! Learn more about it and submit an abstract here: https://t.co/9Hq3NpVh1r
UCSF hiring Researcher/Asst Dir @UCSF_TRANSPERS. Join world-class university/ highly regarded center on policy & precision medicine. Focus on research & mgmt; non-faculty (salaried); can lead grants/PI status if qualified. Flexible, hybrid. https://t.co/xrRvYj4w4H
UCSF Open Rank Professor Health Policy @UCSF_TRANSPERS@UCSF_IHPS. Join world-class university/top policy centers. Grant-supported research; addl support for PT role Asst Dir Research & for teaching/service; start-up funds. Flexible, hybrid. https://t.co/4wiJmaYaqf
FANTASTIC #career opportunity for senior #health#economist. ARPA-H is undoubtedly an exciting place to be & offers fast-paced and rewarding work! https://t.co/qtv2oMDuBG
In case you missed our newsletter last week, take a look. We touch on Key Fall Conferences & Launch of a New Policy Journal - Health Affairs Scholar.
https://t.co/Uoz4or4xUS
Important work from TRANSPERS Colleague @Marshall_HEcon - SOLVE Framework will improve the accuracy and certainty associated with value-based assessments of genomic sequencing in diagnosing rare diseasehttps://www.sciencedirect.com/science/article/pii/S1098360021053831
GEECS Members convened in sunny San Diego for their annual meeting Tuesday, Sept. 27 where they shared info on their ongoing studies and discussed possible new GEECS projects.
Congrats to GEECS Affiliate @tara_lavelle and the team @TuftsCEVR on their just published CE of #exome and #genome sequencing. First-line GS may be the most cost-effective strategy for diagnosing infants with suspected genetic conditions. https://t.co/hEDov18zLs
There is a need for a centralized database of PM Utilization. Our scoping review on the utilization of Precision Medicine with real-world data finds registries and claims data common sources with 2/3rd of cancer studies. @UCSF_TRANSPERS@MDPIOpenAccess https://t.co/xmbkIZGR1w
Congratulations to @Marshall_HEcon and colleagues - very important recently funded work on the socioeconomic impact of living with rare disease. https://t.co/MpyzhkB8uj
Congrats to @GEECSEcon members, @JeroenPJansen, and @KathrynP_phd on their publication using CEAs to assess health equity impact in underrepresented populations.
Pleased to publish paper w/ @UCSF_TRANSPERS colleague @JeroenPJansen arguing that cost-effectiveness analyses need to assess health equity impact on subpopulations as interventions can have differential impact that will be missed otherwise https://t.co/9X4WMShtH8
Early initiation of ultra-rapid genomic testing can offer substantial economic and personal benefits. Congrats to @IliasGoranitis and Team on their economic evaluation of rapid and ultra-rapid genomic testing in critically ill infants and children!
[1] Is faster better? An economic evaluation of rapid and ultra-rapid genomic testing in critically ill infants and children | @IliasGoranitis@ClaraGaff@ZornitzaS | https://t.co/mq0zk3mf31
#healtheconomics [2/2]
Do you have any news on the economics of genomics & precision medicine #EconGenomics? Let us know about your paper, presentation, events, grants, collaboration opportunities, etc
Tell us via [email protected] & we'll tweet it in our weekly compilation
Our study w/ @JuliaTrosman@TRANSPERS@GEECSEcon and @hail_CSER collaborators published in @GIMJournal on why payers are less likely to cover genome v. exome sequencing and what evidence needs to be developed to move forward
https://t.co/8VQTEX2kQ9
TRANSPERS seeks applicants for Assist./Assoc. Prof. in Health Services Res. with relevant expertise (e.g., economics, health policy, financing/payment). Possible 1-2 years of start-up support to enable applicant to develop and obtain funding. Apply online https://t.co/V28dbVqKeC
Congrats to colleagues Sarah Wordsworth and @jbuchanan_ox - 100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care — Preliminary Report | @NEJM https://t.co/tmeMkvTbIL
Congratulations to our colleague, Deborah Marshall, on the being awarded a CIHR grant to lead National Cohort Training Program for their Health System Impact Fellows.
TRANSPERS NEWSLETTER Summer 2021: New Deputy Director | TRANSPERS Study Top Citation in Genetics in Medicine | Aducanumab Controversy https://t.co/sV64zMMVb4